These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 15201783

  • 1. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study.
    Giannantoni A, Di Stasi SM, Stephen RL, Bini V, Costantini E, Porena M.
    J Urol; 2004 Jul; 172(1):240-3. PubMed ID: 15201783
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions.
    Kuo HC.
    J Urol; 2003 Sep; 170(3):835-9. PubMed ID: 12913711
    [Abstract] [Full Text] [Related]

  • 3. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Giannantoni A, Mearini E, Del Zingaro M, Porena M.
    Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
    [Abstract] [Full Text] [Related]

  • 4. New therapeutic options for refractory neurogenic detrusor overactivity.
    Giannantoni A, Mearini E, Di Stasi SM, Costantini E, Zucchi A, Mearini L, Fornetti P, Del Zingaro M, Navarra P, Porena M.
    Minerva Urol Nefrol; 2004 Mar; 56(1):79-87. PubMed ID: 15195033
    [Abstract] [Full Text] [Related]

  • 5. Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study.
    Giannantoni A, Di Stasi SM, Stephen RL, Navarra P, Scivoletto G, Mearini E, Porena M.
    J Urol; 2002 Apr; 167(4):1710-4. PubMed ID: 11912393
    [Abstract] [Full Text] [Related]

  • 6. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
    Schurch B, de Sèze M, Denys P, Chartier-Kastler E, Haab F, Everaert K, Plante P, Perrouin-Verbe B, Kumar C, Fraczek S, Brin MF, Botox Detrusor Hyperreflexia Study Team.
    J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
    [Abstract] [Full Text] [Related]

  • 7. Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity.
    Karsenty G, Reitz A, Lindemann G, Boy S, Schurch B.
    Urology; 2006 Dec; 68(6):1193-7. PubMed ID: 17141831
    [Abstract] [Full Text] [Related]

  • 8. Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity.
    Giannantoni A, Di Stasi SM, Nardicchi V, Zucchi A, Macchioni L, Bini V, Goracci G, Porena M.
    J Urol; 2006 Jun; 175(6):2341-4. PubMed ID: 16697870
    [Abstract] [Full Text] [Related]

  • 9. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
    Kuo HC.
    Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.
    Gamé X, Castel-Lacanal E, Bentaleb Y, Thiry-Escudié I, De Boissezon X, Malavaud B, Marque P, Rischmann P.
    Eur Urol; 2008 Mar; 53(3):613-8. PubMed ID: 17804150
    [Abstract] [Full Text] [Related]

  • 11. Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction.
    Pannek J, Göcking K, Bersch U.
    BJU Int; 2009 Nov; 104(9):1246-50. PubMed ID: 19426192
    [Abstract] [Full Text] [Related]

  • 12. Refractory neurogenic detrusor overactivity.
    Cruz F, Silva C.
    Int J Clin Pract Suppl; 2006 Dec; (151):22-6. PubMed ID: 17169007
    [Abstract] [Full Text] [Related]

  • 13. [Efficacy of repeat injections of botulinum A toxin to the detrusor in neurogenic bladder overactivity].
    Chenet A, Perrouin-Verbe B, Le Normand L, Labat JJ, Brunel P, Lefort M, Mathé JF.
    Ann Readapt Med Phys; 2007 Nov; 50(8):651-60. PubMed ID: 17490775
    [Abstract] [Full Text] [Related]

  • 14. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.
    Reitz A, Stöhrer M, Kramer G, Del Popolo G, Chartier-Kastler E, Pannek J, Burgdörfer H, Göcking K, Madersbacher H, Schumacher S, Richter R, von Tobel J, Schurch B.
    Eur Urol; 2004 Apr; 45(4):510-5. PubMed ID: 15041117
    [Abstract] [Full Text] [Related]

  • 15. Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?
    Kessler TM, Danuser H, Schumacher M, Studer UE, Burkhard FC.
    Neurourol Urodyn; 2005 Apr; 24(3):231-6. PubMed ID: 15747344
    [Abstract] [Full Text] [Related]

  • 16. Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity.
    Reitz A, Denys P, Fermanian C, Schurch B, Comperat E, Chartier-Kastler E.
    Eur Urol; 2007 Dec; 52(6):1729-35. PubMed ID: 17884281
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A, Rossi A, Mearini E, Del Zingaro M, Porena M, Berardelli A.
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [Abstract] [Full Text] [Related]

  • 18. A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity.
    Rajkumar GN, Small DR, Mustafa AW, Conn G.
    BJU Int; 2005 Oct; 96(6):848-52. PubMed ID: 16153215
    [Abstract] [Full Text] [Related]

  • 19. Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder.
    Haferkamp A, Schurch B, Reitz A, Krengel U, Grosse J, Kramer G, Schumacher S, Bastian PJ, Büttner R, Müller SC, Stöhrer M.
    Eur Urol; 2004 Dec; 46(6):784-91. PubMed ID: 15548448
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic effects of suburothelial injection of botulinum a toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions.
    Kuo HC.
    Urology; 2006 Feb; 67(2):232-6. PubMed ID: 16442605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.